Scholars Central

Conference abstractPublished 10 Sep 2012

Theranostic nanoparticles for personalized cancer therapy

Authors: Lily Yang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Resistance to therapy and development of recurrent tumors are the major challenges in clinical oncology. Human tumors are highly heterogeneous with multiple genetic and signal pathway abnormalities. Effective cancer treatment will require integrated approaches that include early detection, targeted therapy, and tumor imaging for monitoring treatment responses. Multifunctional nanoparticles offer great opportunities to develop novel image-treatment approaches that are based on the single nanoparticle platforms. We have developed multifunctional magnetic iron oxide nanoparticles (IONPs) that are targeted to epidermal growth factor receptor, Her-2/Neu, and urokinase plasminogen activator receptor, which are cellular receptors highly expressed in many types of human cancers. These receptor-targeted IONPs are engineered to carry single or multiple drugs for targeted delivery, multi-modality tumor imaging for monitoring treatment responses, and image-guided surgical removal of drug resistant tumors. We have shown specificity and sensitivity of tumor imaging using those nanoparticles in orthotopic human breast, pancreatic and ovarian cancer xenograft models. We further developed theransotic nanoparticles by encapsulating or conjugating drugs into the nanoparticles. Efficacy of targeted therapy and MRI-monitoring drug delivery and response after systemic delivery of the theranostic nanoparticles has been demonstrated in above animal tumor models. To prevent tumor recurrence, hand-held imaging devices have also been developed for image-guided surgery to detect and remove drug resistant tumor lesions in the surgical cavity. The ultimate goal of our research is to translate the targeted therapy and image-guided treatment and surgery protocol into clinical applications for personalized management of cancer patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Lily Yang”